ACIN - ETF AI Analysis

Top Page

Hartford Alpha Capture International Equity ETF (ACIN)

Rating:65Neutral

Price Target:$43.00▲(5.47% Upside)

ACIN, the Hartford Alpha Capture International Equity ETF, appears to be a solid, well‑constructed fund, supported by strong holdings like AstraZeneca, TotalEnergies, and DBS Group, which bring robust financial performance, positive earnings sentiment, and generally attractive valuations. The rating is held back somewhat by names such as Shell and National Grid, where high leverage, cash flow challenges, and short‑term technical weakness introduce additional risk. The main risk factor is that several key holdings show signs of high or potentially stretched valuations, which could limit future upside if market conditions change.

Positive Factors

Strong Leading HoldingsSeveral of the largest positions, including ASML, TotalEnergies, Shell, and DBS Group, have shown strong year-to-date performance, helping support the fund’s returns.

Broad International DiversificationThe ETF spreads its investments across many countries such as Japan, the UK, the U.S., and several European markets, which helps reduce the impact of weakness in any single region.

Balanced Sector MixHoldings are spread across financials, industrials, health care, consumer sectors, energy, and technology, offering a mix of defensive and growth exposure rather than relying on one industry.

Negative Factors

Moderate Expense RatioThe fund’s fee is not extremely high but is meaningfully above the cheapest index ETFs, which can slightly reduce long-term returns for buy-and-hold investors.

Heavy Country TiltsLarge weights in Japan, the UK, and the U.S. mean the ETF’s performance is heavily influenced by these markets, which can be a risk if they go through a weak period.

Mixed Overall Performance So Far This YearYear-to-date performance has been only slightly positive, suggesting that while some holdings are strong, the fund as a whole has not strongly outpaced the broader market.

ACIN vs. SPDR S&P 500 ETF (SPY)

AUM: 559.95M
Region: Global
Expense Ratio: 0.52%
Beta: N/A
Issuer: Hartford
Inception Date: Oct 26, 2026
Dividend Yield: N/A
Asset Class: Equity
Index Tracked: No Underlying Index

ACIN Summary

Hartford Alpha Capture International Equity ETF (ACIN) is an international stock fund that aims for long-term growth by investing in large, established companies outside the U.S. It doesn’t track a specific index, but follows a broad global theme with major exposure to countries like Japan, the UK, and Europe across many sectors. Well-known holdings include ASML Holding and Unilever. Investors might consider ACIN to diversify beyond U.S. stocks and tap into global growth. However, its value can go up and down with international markets and currency swings, so returns may be volatile.

How much will it cost me?

This ETF has an expense ratio of 0.52%, which means you’ll pay about $5.20 per year for every $1,000 invested. That’s higher than the average low-cost index ETF because it’s actively managed, aiming to select international stocks to outperform the broader market.

What would affect this ETF?

ACIN could benefit from global economic growth, stable or falling interest rates, and strong performance in sectors like financials, health care, and technology, as well as continued success of major holdings such as ASML, Unilever, and leading energy and bank stocks. On the downside, rising interest rates, economic slowdowns in key regions outside the U.S., sector-specific challenges in financials or energy, and regulatory changes affecting large international companies could weigh on the ETF’s future returns.

ACIN Top 10 Holdings

This ETF leans heavily on international blue chips, with European health care and energy names doing much of the heavy lifting. AstraZeneca and Roche have been rising steadily, giving the fund a solid defensive backbone, while TotalEnergies and Shell add punch from the energy patch as they continue to climb. ASML, a key semiconductor player, has lost some steam lately, and financials like UniCredit and DBS Group show mixed momentum, occasionally dragging on returns. Overall, it’s a globally diversified, non-U.S. large-cap mix with a tilt toward Europe’s corporate heavyweights.

ACIN top ten holdings
Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
NL:ASML	ASML Holding NV	3.60%	$20.10M	EUR 519.88B	58.28%	76Outperform
GB:ULVR	Unilever	2.29%	$12.79M	GBP 106.40B	-5.19%	72Outperform
GB:NG	National Grid	2.12%	$11.81M	GBP 62.66B	7.31%	76Outperform
RHHVF	Roche Holding AG	―	―	―	―	73Outperform
FR:TTE	TotalEnergies SE	2.01%	$11.21M	EUR 174.56B	43.42%	78Outperform
IT:UCG	UniCredit SpA	2.09%	$11.64M	EUR 125.99B	26.41%	75Outperform
AZN	AstraZeneca	―	―	―	―	80Outperform
FR:ENGI	Engie SA	1.88%	$10.51M	EUR 62.61B	16.41%	64Neutral
CH:NOVN	Novartis AG	1.75%	$9.74M	CHF 246.17B	27.54%	80Outperform
DBSDF	DBS Group Holdings	―	―	―	―	78Outperform

ACIN Technical Analysis

Technical Analysis SentimentPositive

Last Price40.77

Price Trends

Market Momentum

STOCH82.49Negative

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ACIN, the sentiment is Positive. The current price of 40.77 is compared to the 20-day moving average (MA) of , compared to the 50-day MA of , and compared to the 200-day MA of , indicating a neutral trend. The MACD of indicates Neutral momentum. The RSI at is Neutral, neither overbought nor oversold. The STOCH value of 82.49 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ACIN.

ACIN Peer Comparison

Comparison Results

ACIN against its peer funds
Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
ACIN	$40.77	$43.00(5.47% Upside)	$559.95M	0.52%	65Neutral
FHEQ	$33.06	$39.80(20.40% Upside)	$992.54M	0.48%	72Outperform
AQEC	$26.15	$31.17(19.18% Upside)	$606.82M	0.49%	72Outperform
BBHL	$17.80	$20.88(17.30% Upside)	$532.18M	0.71%	70Outperform
TEQI	$53.81	$60.92(13.22% Upside)	$479.52M	0.54%	69Neutral
FYEE	$29.69	$35.73(20.36% Upside)	$344.28M	0.28%	72Outperform

Performance Comparison

ACIN and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
ACIN	Hartford Alpha Capture International Equity ETF	40.77	0.68	1.69%
FHEQ	Fidelity Hedged Equity ETF	33.06	2.50	8.19%
AQEC	AQE Core ETF	26.15	1.47	5.95%
BBHL	BBH Select Large Cap ETF	17.80	2.11	13.43%
TEQI	T. Rowe Price Equity Income ETF	53.81	10.77	25.03%
FYEE	Fidelity Yield Enhanced Equity ETF	29.69	3.77	14.52%

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.